1256037-62-3
1256037-62-3 structure
- Name: TRX-818 sodium
- Chemical Name: Foslinanib Disodium
- CAS Number: 1256037-62-3
- Molecular Formula: C16H11FNNa2O5P
- Molecular Weight: 409.213
- Create Date: 2020-01-11 19:01:01
- Modify Date: 2023-01-11 18:23:23
-
TRX-818 sodium (Foslinanib sodium ) is an orally bioavailable agent with potential antineoplastic and anti-vasculogenic mimicry (VM) activities, induces cancer cell apoptosis and inhibits cancer cell proliferation; also prevents tumor cell VM by blocking the formation of vasculogenic-like tubular structures through an as of yet undetermined mechanism of action. Liver Cancer Phase 2 Clinical
| Name | Foslinanib Disodium |
|---|---|
| Synonyms |
4(1H)-Quinolinone, 2-(3-fluorophenyl)-6-methoxy-5-(phosphonooxy)-, sodium salt (1:2)
Foslinanib Disodium Disodium 2-(3-fluorophenyl)-6-methoxy-4-oxo-1,4-dihydro-5-quinolinyl phosphate |
| Description | TRX-818 sodium (Foslinanib sodium ) is an orally bioavailable agent with potential antineoplastic and anti-vasculogenic mimicry (VM) activities, induces cancer cell apoptosis and inhibits cancer cell proliferation; also prevents tumor cell VM by blocking the formation of vasculogenic-like tubular structures through an as of yet undetermined mechanism of action. Liver Cancer Phase 2 Clinical |
|---|---|
| References | References View Related Products by Target Other Targets Liver Cancer |
| Molecular Formula | C16H11FNNa2O5P |
|---|---|
| Molecular Weight | 409.213 |
| Exact Mass | 409.010345 |